Quality challenge
Proof over packaging. Assay over hype.
Mr Pep publishes an open stance: if a vendor claims milligrams in a multi-peptide blend, they should be able to show independent lab data — stamped, sequenced, and ratio-correct. Convenience blends that ignore pharmacokinetics are not “advanced.” They are often confused science.
Timing mismatch
TB-500 research commonly uses multi-day intervals. BPC-157 is often studied daily. A single pre-mixed injection schedule cannot optimize both. If the timeline is wrong, the blend is theater.
Cost ratio games
When one component costs several times more than another, a blend can legally list both names while the expensive peptide is the minority. GHK-Cu is often far cheaper than recovery actives — easy filler in a “premium” glow mix.
Label vs lab
Marketing cards are not certificates of analysis. Independent state-lab style assay data — identity, purity percentage, and relative content — is the only serious language. We challenge anyone to prove contradictory assay claims with better stamped data.
No medical storefront
This site does not sell peptides. It documents research integrity principles so buyers and labs can ask harder questions of anyone who does sell. Research use only. No treatment claims.
Bring better lab data. We will update.
Mr Pep stands behind transparent research framing. If third-party assays contradict a public claim about common blend ratios or purity — publish the stamped report. Integrity is a conversation with numbers, not slogans. Until then, treat pre-mix milligram claims with scientific skepticism.
Note: This page does not display medical or regulatory endorsements. Any research collaboration context is internal and is not represented as official agency approval.
Review single-compound profiles